Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lifshitz Law PLLC Announces Investigations of Amplitude, Inc. (NASDAQ: AMPL), Doximity, Inc. (NYSE: DOCS), Globe Life, Inc. (NYSE: GL), and iRhythm Technologies, Inc. (NASDAQ: IRTC)

IRTC, GL, DOCS, AMPL

NEW YORK, NYY / ACCESSWIRE / July 23, 2024 /

Amplitude, Inc. (NASDAQ:AMPL)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) Amplitude's land-and-expand strategy was years away from significantly accelerating revenues among its newer client cohorts; (ii) the rapid acceleration in the Company's 2Q21 results resulted from the ephemeral effects of the COVID-19 pandemic which had not continued by the start of the Relevant Period, as Amplitude clients were expanding at a slower pace; and (iii) as a result, Amplitude's business, operations, financial results, and prospects were materially worse than represented to investors during the Relevant Period.

If you are an AMPL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Doximity, Inc. (NYSE:DOCS)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information about the Company's business and operations. Specifically, the Company repeatedly touted its business prospects and the sustainability of the Company's revenue growth and profitability, while downplaying the impact of competition and tightening macroeconomic conditions on the Company and Doximity's reliance on "upselling" products and services (such as additional advertising) to existing customers to sustain the Company's performance and future growth.

If you are a DOCS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Globe Life, Inc. (NYSE:GL)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements concerning: (i) Globe Life's consistent premium revenue growth, particularly from AIL - the largest of Globe Life's subsidiaries; and (ii) Globe Life's Code of Business Conduct and Ethics. More specifically, the Company repeatedly attributed its consistent premium revenue growth "to increased agent count and productivity." As a result of these misrepresentations, Globe Life common stock traded at artificially inflated prices during the Relevant Period.

If you are a GL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

iRhythm Technologies, Inc. (NASDAQ:IRTC)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the Company falsely represented to investors that the Zio AT monitor was a real-time monitor intended for high-risk patients; (ii) the Company repeatedly touted the potential growth for the Zio AT as an innovative product that had only just begun to penetrate the market for real-time monitoring, which investors looked upon favorably given the premium selling price associated with devices approved for high-risk patients; and (iii) as a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices.

If you are an IRTC investor and owned the shares during the period of alleged wrongs, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

ATTORNEY ADVERTISING.© 2024 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@lifshitzlaw.com

SOURCE: Lifshitz Law Firm



View the original press release on accesswire.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today